Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

114.07
-0.5700-0.50%
Post-market: 114.070.00000.00%16:16 EDT
Volume:259.23K
Turnover:29.54M
Market Cap:2.20B
PE:-16.05
High:114.94
Open:114.94
Low:112.42
Close:114.64
Loading ...

Stock Track | Ligand Pharmaceuticals Plunges 5.06% as 2024 Results and Acquisition Come Under Scrutiny

Stock Track
·
03 Mar

Ligand to Participate in March Investor Conferences

GlobeNewswire
·
03 Mar

LGND: First Steps into Cell & Gene Therapy

Zacks Small Cap Research
·
03 Mar

Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth

TIPRANKS
·
01 Mar

Stock Track | Ligand Pharmaceuticals Soars 5.07% on Strong Earnings, New Product Launches, and Positive Outlook

Stock Track
·
01 Mar

Ligand Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
28 Feb

RBC Raises Price Target on Ligand Pharmaceuticals to $155 From $143, Keeps Outperform Rating

MT Newswires Live
·
28 Feb

Ligand Pharmaceuticals Inc (LGND) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Ligand Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
28 Feb

Ligand Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Stock Track | Ligand Pharmaceuticals Soars 6.32% on Thursday Following Q4 Earnings Beat and Upbeat 2025 Guidance

Stock Track
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Madrigal Pharmaceuticals (MDGL) and Ligand Pharma (LGND)

TIPRANKS
·
27 Feb

Ligand Pharmaceuticals' Q4 Core Adjusted Net Income, Total Revenue Rise; 2025 Guidance Set

MT Newswires Live
·
27 Feb

Craig-Hallum Reaffirms Their Buy Rating on Ligand Pharma (LGND)

TIPRANKS
·
27 Feb

Ligand: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Ligand Pharmaceuticals Q4 2024 Adj EPS $1.27 Beats $1.19 Estimate, Sales $42.81M Beat $39.02M Estimate

Benzinga
·
27 Feb

BRIEF-Ligand Pharmaceuticals Q4 EPS USD -1.64

Reuters
·
27 Feb

Ligand Pharmaceuticals Q4 EPS USD -1.64

THOMSON REUTERS
·
27 Feb

Ligand Pharmaceuticals Q4 Pretax Profit USD -39.2 Million

THOMSON REUTERS
·
27 Feb

Ligand Pharmaceuticals Inc Qtrly Core Adj EPS From Continuing Operations $1.27

THOMSON REUTERS
·
27 Feb